The vector of anti-NY-ESO-1 T cell receptor (TCR) is constructed for the engineering of T cell to target Human NY-ESO-1. The T cells are genetically modified through transduction with a retroviral vector expressing NY-ESO-1-specific T cell receptor. And the vector product was designed for the treatment of Melanoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|TCR-L080||Murinized (from Human) anti-CTAG1A (WITQCFLPVFLAQPPSGQRA) T Cell Receptor[Cysteine-modiﬁed], pMSGV1|
|TCR-L076Z||Mouse anti-NY-ESO-1 (aa157-165) T cell receptor, pCDTCR1|
|TCR-L083||Murinized (from Human) anti-CTAG1A (SLLMWITQC) T Cell Receptor, pSFG|
|VP-TCR-C042||Lenti-NY-ESO-1 (SLLMWITQC) T cell receptor (1G4) Viral Particle|
|VP-TCR-C050||Lenti-NY-ESO-1 (CFLPVFLAQPPSGQR) T cell receptor Viral Particle|
|TCR-L082Z||Murinized anti-NY-ESO-1 (aa157-165) T cell receptor, pCDTCR1|
|TCR-L080Z||Human anti-NY-ESO-1 (aa161-180) T cell receptor, pCDTCR1|
|TCR-L079||Human anti-CTAG1A (WITQCFLPVFLAQPPSGQRA) T Cell Receptor, pMSGV1|
|TCR-L081Z||Mouse anti-NY-ESO-1T cell receptor, pCDTCR1|
|VP-TCR-C052||Lenti-NY-ESO-1 T cell receptor (Cysteine-modiﬁed) Viral Particle|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved